Idera pharmaceuticals, inc. (IDRA)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets:
Cash and cash equivalents

27,909

40,019

32,611

39,884

24,198

71,431

82,462

94,046

107,459

112,629

63,941

74,659

79,694

80,667

22,154

24,064

21,879

26,586

27,996

36,369

92,273

19,971

48,491

54,886

60,748

26,278

38,749

16,301

6,149

10,096

8,352

13,227

18,689

24,571

18,078

21,492

17,008

Short-term investments

5,578

2,774

8,975

12,489

35,666

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term investments

-

-

-

-

-

-

-

-

-

-

1,400

2,576

11,568

28,347

29,856

-

-

33,574

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

37,391

40,511

-

38,028

39,368

21,187

21,256

9,789

8,844

9,896

3,125

-

-

-

-

-

-

-

-

1,003

2,016

17,635

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

311

311

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

2,422

3,475

3,488

1,567

1,736

1,376

2,518

3,923

2,651

3,992

3,669

4,209

4,235

2,030

3,455

3,094

3,129

3,082

2,358

1,602

1,735

1,203

1,102

836

1,160

874

397

202

176

198

144

245

257

255

471

837

997

Total current assets

35,909

46,268

45,074

53,940

61,600

72,807

84,980

97,969

110,110

116,621

69,010

81,444

95,497

111,044

55,465

64,549

65,519

63,242

68,382

77,339

115,195

42,430

59,382

64,566

71,804

30,277

39,457

16,814

6,325

10,294

8,496

13,472

18,946

24,826

19,552

24,345

35,640

Long-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,408

-

-

26,997

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,641

11,732

-

28,670

30,567

3,417

7,344

-

1,004

-

6,189

-

-

-

-

-

-

-

-

-

-

-

Property and equipment, net

80

97

123

151

176

207

241

1,225

1,320

1,472

1,412

1,600

1,744

1,853

1,579

1,707

1,727

1,692

1,685

1,575

1,354

1,306

926

686

125

90

116

144

178

218

268

323

375

458

577

697

930

Operating lease right-of-use asset

1,007

1,054

125

171

216

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

70

70

70

70

-

9

9

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

-

-

-

-

9

-

-

320

321

324

-

-

-

334

-

340

342

345

347

350

344

346

324

-

-

311

-

-

-

-

-

-

-

-

-

-

-

Restricted cash and other assets

-

-

-

-

-

-

-

-

-

-

327

329

332

-

26

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

311

311

-

-

-

311

311

311

311

311

311

311

311

311

Total assets

37,066

47,489

45,392

54,332

62,001

73,023

85,230

99,514

111,751

118,417

70,749

83,373

97,573

113,231

58,478

69,237

79,320

92,276

99,084

109,831

120,310

51,426

60,632

66,567

72,240

36,867

39,573

16,958

6,814

10,823

9,075

14,106

19,632

25,595

20,440

25,353

36,881

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Accounts payable

941

457

321

457

895

1,134

1,036

1,118

1,668

1,334

849

529

1,353

556

344

629

958

1,169

881

2,845

2,064

2,458

2,064

2,026

707

904

254

767

977

1,129

1,377

2,297

2,043

1,203

1,048

1,139

1,757

Accrued expenses

7,385

7,461

7,307

5,939

5,179

7,884

9,171

12,721

10,224

8,000

6,119

5,950

4,369

7,394

6,118

5,047

2,797

4,274

4,571

3,411

3,901

4,460

4,616

4,221

4,647

3,506

2,204

2,257

3,097

3,002

2,870

2,515

3,447

4,882

2,544

2,523

1,783

Operating lease liability

162

163

138

189

202

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Future tranche right liability

25,725

46,436

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Note payable

-

-

-

-

-

-

-

-

131

209

285

309

300

292

284

276

269

261

254

247

175

128

59

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

94

235

376

566

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of deferred revenue

-

-

-

-

-

-

-

-

-

-

563

563

985

1,111

1,111

1,111

1,111

1,111

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

34,213

54,517

7,766

6,585

6,276

9,018

10,301

14,074

12,399

10,109

7,816

7,351

7,007

9,353

7,857

7,063

5,135

6,815

5,706

6,503

6,140

7,046

6,739

6,247

5,354

4,410

2,458

3,024

4,074

4,131

4,247

4,812

5,490

6,085

3,592

3,662

3,540

Warrant liability, long-term

2,140

3,241

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability, net of current portion

857

899

-

-

35

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, net of current portion

-

-

-

-

-

-

-

-

-

-

94

235

-

152

429

707

985

1,262

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Note payable, net of current portion

-

-

-

-

-

-

-

-

-

-

-

50

131

209

285

359

431

501

569

636

700

742

804

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,178

-

-

-

Other liabilities

-

-

-

12

18

11

63

374

468

613

759

865

244

168

35

59

91

116

151

183

205

236

268

59

4

5

6

7

30

65

-

-

-

387

-

-

-

Warrant and other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,172

1,316

2,650

-

-

-

240

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

195

217

-

Total liabilities

37,210

58,657

7,766

6,597

6,329

9,029

10,364

14,448

12,867

10,722

8,669

8,501

7,382

9,882

8,606

8,188

6,642

8,694

6,426

7,322

7,045

8,024

7,811

6,306

5,358

4,415

2,464

3,031

4,104

4,196

5,419

6,128

8,140

7,650

3,787

3,879

3,780

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Series D Redeemable Convertible Preferred Stock, $0.01 par value, Designated, issued and outstanding - 1,124 shares at December 31, 2012

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,921

5,921

5,921

5,921

5,921

5,921

-

-

0

Stockholders’ equity (deficit)
Preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

0

0

0

0

0

0

0

-

0

0

0

0

-

0

0

0

Common stock, $0.001 par value, Authorized — 70,000 shares; Issued and outstanding — 30,607 and 29,672 at March 31, 2020 and December 31, 2019, respectively

31

30

29

29

28

27

27

27

216

24

150

150

149

149

121

121

121

121

118

118

118

95

86

84

82

66

63

45

28

28

28

28

28

28

28

28

28

Additional paid-in capital

711,898

709,692

735,254

734,229

730,991

728,342

727,064

725,659

723,257

712,165

651,498

649,761

643,611

641,687

589,044

587,305

585,461

583,676

580,658

579,194

577,153

494,850

486,817

484,799

483,113

434,285

432,848

404,946

391,525

391,635

388,567

388,220

387,847

387,414

386,883

386,215

384,702

Accumulated deficit

-712,073

-720,890

-697,658

-686,525

-675,349

-664,375

-652,225

-640,620

-624,589

-604,494

-589,568

-575,038

-553,568

-538,470

-539,292

-526,389

-512,904

-500,081

-488,091

-476,726

-464,007

-451,526

-439,608

-430,153

-421,845

-412,884

-406,794

-402,056

-398,465

-394,658

-390,860

-386,191

-382,304

-375,418

-370,258

-364,769

-351,642

Accumulated other comprehensive income

-

-

1

2

2

-

-

-

-

-

-

-1

-1

-17

-1

12

-

-134

-27

-77

1

-17

-2

3

4

-7

-

-

-

-

-

-

-

-

0

0

13

Total stockholders’ deficit

-144

-11,168

37,626

47,735

55,672

63,994

74,866

85,066

98,884

107,695

62,080

74,872

90,191

103,349

49,872

61,049

72,678

83,582

92,658

102,509

113,265

43,402

52,821

60,261

66,882

32,452

37,109

13,927

-3,211

706

-2,265

2,057

5,571

12,024

16,653

21,474

33,101

Total liabilities and stockholders’ deficit

37,066

47,489

45,392

54,332

62,001

73,023

85,230

99,514

111,751

118,417

70,749

83,373

97,573

113,231

58,478

69,237

79,320

92,276

99,084

109,831

120,310

51,426

60,632

66,567

72,240

36,867

39,573

16,958

6,814

10,823

9,075

14,106

19,632

25,595

20,440

25,353

36,881